SCHEMBL20152325

SCHEMBL20152325

c1ccc([Si]2(c3ccccc3)c3ccccc3N3c4ccccc4-c4ccccc4-c4cccc2c43)cc1

nearest known ligand 0.31

Predicted protein targets (top 7)

geneUniProtsupporting neighboursconfidence
MGLL Q99685 1/20 0.31
CES2 O00748 1/20 0.31
ALDH1A1 P00352 1/20 0.31
BCHE P06276 1/20 0.31
GAA P10253 1/20 0.31
CES1 P23141 1/20 0.31
NPSR1 Q6W5P4 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20022915 0.86 ALDH1A1 (0.36) MGLLCES2ALDH1A1BCHEGAA
SCHEMBL19035965 0.86
SCHEMBL20152330 0.80 ALDH1A1 (0.33) MGLLCES2ALDH1A1BCHEGAA
SCHEMBL20997795 0.77 MGLL (0.34) MGLL
SCHEMBL20152335 0.76
SCHEMBL15960558 0.76
SCHEMBL20997810 0.76 NOTUM (0.35) MGLLALDH1A1
SCHEMBL20998059 0.75 AKT1 (0.46)
SCHEMBL20997989 0.75 HTR7 (0.40) ALDH1A1
SCHEMBL20152324 0.75 MEN1 (0.35) MGLLNPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10844059-B2 Heterocyclic compound and organic electroluminescence device including the same SAMSUNG DISPLAY CO., LTD. (KR) 2020-11-24 US disclosed
US-20180134706-A1 HETEROCYCLIC COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2018-05-17 US disclosed
US-20180134706-A1 HETEROCYCLIC COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2018-05-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180134706-A1 HETEROCYCLIC COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE INCLUDING THE SAME OR10J3, HDAC10, RBM12 MGLL 4818/4885CES2 2120/4885ALDH1A1 2082/4885
US-10844059-B2 Heterocyclic compound and organic electroluminescence device including the same OR10J3, HDAC10, RBM12 MGLL 4818/4885CES2 2120/4885ALDH1A1 2082/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.